美國山地時間10月7日至11日，浙江“90後”藥師林彬受邀參加在美國鳳凰城舉行的2017年美國臨床藥學年會。他將團隊的研究成果《四氫姜黃素通過PI3K/mTOR/AKT信號通路誘導非小細胞肺癌自噬抑制腫瘤增殖的機制研究》向全球同行展示，受到外界的廣泛關注與讚許。

From October 7th to 11th, American MT, Lin Bin, "post 90s" pharmacist of Zhejiang was invited to participate in 2017 ACCP held in Phoenix, the United States. He showed his team's research results --Study on Mechanism of Tetrahydrocurcumin Leads Autophagy of NSCLC and Inhibition of Tumor Proliferation through PI3K/mTOR/AKT Signal Channel to the global peers and received widespread attention and praise from the world.

　　據了解，美國臨床藥學年會（ACCP）是全球臨床藥學界最頂級的學術盛宴，此次會議共有來自全球各地的2000多名專家學者參會，圍繞臨床藥學實踐、科研和教學三大主題交流臨床藥學領域的最新進展。

It is understood that the American College of Clinical Pharmacy (ACCP) is the world's top academic feast of clinical pharmacy. More than 2000 experts and scholars from all over the world attended the meeting, and the latest progress of clinical pharmacy was exchanged with three major themes: clinical pharmacy practice, scientific research and teaching.

　　林彬及團隊所研究的四氫姜黃素是從中藥溫鬱金中提取得到的一種化合物，具有抗腫瘤、抗氧化作用。

Tetrahydrocurcumin researched by Lin Bin and his team, is a chemical compound obtained from traditional Chinese Medicine Radix Curcumae with effects of anti-tumor and antioxidant.

　　會議期間，林彬還受邀參加ACCP的國際交流座談會。該座談會為邀請制，僅限美國之外的國際藥師參加，共10人。林彬向各國同行彙報了長興縣人民醫院臨床藥學工作，得到與會專家、藥師普遍好評，並收到了ACCP大會主席親自授予的明年將在西雅圖舉行的Global Conference特別邀請函。

During the meeting, Lin Bin was also invited to participate in the ACCP international exchange forum. The forum was by invitation only and only 10 international pharmacists were invited to participate outside the United States. Lin Bin reported the clinical pharmacy in Changxing the people's Hospital to counterparts around the world, which was praised by the experts and the pharmacists widely, and received a special invitation of Global Conference held in Seattle next year awarded personally by Dr. Terry L. Seaton, the chairman of ACCP.

　　（中國網綜合  翻譯：杜依依）

來源： 中國網綜合    | 作者：中國網綜合 翻譯：杜依依    | 責編：胡金    審核：張淵

新聞投稿：184042016@qq.com    新聞熱線：13157110107